The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| BHST | -18.4% | -66.57% | -19.67% | -47% |
| S&P | +12.16% | +74.91% | +11.82% | +143% |
BioHarvest Sciences, Inc. develops bio farming technology. The firm’s products include Vinia, Cannabis, Olivia and Pomia. Its bio-farming technology is capable of directly and constantly producing the active plant ingredients without the necessity to grow the plant itself. Its objective is to become the supplier of Cannabis for both the medicinal and recreational legal use. The company was founded on April 19, 2013 and is headquartered in Vancouver, Canada.
No news articles found for BioHarvest Sciences.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $9.07M | 38.7% |
| Gross Profit | $5.57M | 50.0% |
| Gross Margin | 61.43% | 4.6% |
| Market Cap | $163.05M | 111.8% |
| Market Cap / Employee | $1.87M | 0.0% |
| Employees | 87 | 0.0% |
| Net Income | -$2,513.00K | 6.5% |
| EBITDA | -$535.00K | 69.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $10.97M | 296.2% |
| Accounts Receivable | $1.38M | 18.4% |
| Inventory | 4.4 | 39.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $14.26M | 21.3% |
| Short Term Debt | $5.58M | 367.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -38.97% | 55.5% |
| Return On Invested Capital | 30.88% | -27.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$2,541.65K | -11.7% |
| Operating Free Cash Flow | -$2,114.06K | -20.1% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 25.87 | 80.64 | -133.14 | -38.62 | -365.35% |
| Price to Sales | 4.25 | 3.87 | 3.86 | 5.01 | 15.13% |
| Price to Tangible Book Value | 25.87 | 80.65 | -133.12 | -38.62 | -365.34% |
| Enterprise Value to EBITDA | -90.05 | -92.75 | -96.26 | -323.07 | 424.70% |
| Return on Equity | -5956.0% | -973.2% | -200.2% | - | |
| Total Debt | $16.51M | $18.57M | $22.64M | $19.84M | 53.26% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
